Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUP214 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
XRCC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMM8B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RUNX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRP72 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHD1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JADE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GATAD2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLA2G12A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2AH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CCDC102A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLGRKT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMYD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRMO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NETO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GSPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on